Annual EBITDA
$368.27M$8.11M+2.25%
Summary
- Current Value
- As of today, CON annual EBITDA is $368.27M, up +2.25% on
- Historical Performance
- CON annual EBITDA is down -5.48% over the past 3 years, and down -5.48% over the past 5 years
- All-Time High Comparison
- CON annual EBITDA is currently -5.48% below its historical high of $389.63M set on
- 3-Year Low Comparison
- CON annual EBITDA is +11.53% above its 3-year low of $330.20M reached on an earlier date
- Sector Comparison
- CON annual EBITDA is higher than 90.25% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $368.27M | +2.3% | -5.5% | -5.5% | -5.5% | |
| Quarterly EBITDA | $116.59M | +14.9% | +24.6% | +24.6% | +24.6% | |
| TTM EBITDA | $404.39M | +36.2% | +332.2% | +332.2% | +332.2% | |
| Price | $19.90 | +0.8% | – | – | – | |
| PE Ratio | 16.71 | +11.0% | – | – | – | |
| Annual Revenue | $1.90B | +3.4% | +9.7% | +9.7% | +9.7% | |
| Annual EPS | $1.30 | -8.6% | -21.2% | -21.2% | -21.2% | |
| Annual EBIT | $301.09M | +4.9% | -2.1% | -2.1% | -2.1% | |
| Annual Net Income | $171.90M | -7.0% | -20.4% | -20.4% | -20.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $368.27M | at high | |
| 5Y | $389.63M | -5.5% | |
| All | $389.63M | -5.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $330.20M | N/A | +11.5% |
| 5Y | $330.20M | +11.5% | |
| All | $330.20M | +11.5% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $368.27M | +2.3% | |
| $360.16M | +9.1% |
| Year | Value | Change |
|---|---|---|
| $330.20M | -15.3% | |
| $389.63M | - |
FAQ
What is the current annual EBITDA of CON?
As of today, CON annual EBITDA is $368.27M
What is 1-year change in CON annual EBITDA?
CON annual EBITDA is up +2.25% year-over-year
What is 3-year change in CON annual EBITDA?
CON annual EBITDA is down -5.48% over the past 3 years
How far is CON annual EBITDA from its all-time high?
CON annual EBITDA is currently -5.48% below its historical high of $389.63M set on December 1, 2021
How does CON annual EBITDA rank versus sector peers?
CON annual EBITDA is higher than 90.25% of companies in Healthcare sector
When is CON next annual earnings release?
The next annual earnings release for CON is on
Quarterly EBITDA
$116.59M$3.87M+3.44%
Summary
- Current Value
- As of today, CON quarterly EBITDA is $116.59M, up +3.44% on
- Historical Performance
- CON quarterly EBITDA is up +14.92% year-over-year, and up +24.60% over the past 3 years
- All-Time High Comparison
- CON quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CON quarterly EBITDA is +56.08% above its 3-year low of $74.70M reached on
- Sector Comparison
- CON quarterly EBITDA is higher than 89.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $116.59M | +3.4% | +14.9% | +24.6% | +24.6% | |
| Annual EBITDA | $368.27M | – | +2.3% | -5.5% | -5.5% | |
| TTM EBITDA | $404.39M | +3.9% | +36.2% | +332.2% | +332.2% | |
| Price | $19.90 | -4.7% | +0.8% | – | – | |
| PE Ratio | 16.71 | -4.7% | +11.0% | – | – | |
| Quarterly Revenue | $572.80M | +4.0% | +17.0% | +25.5% | +25.5% | |
| Quarterly EPS | $0.37 | +8.3% | +6.8% | +1.8% | +1.8% | |
| Quarterly EBIT | $96.68M | +3.2% | +12.1% | +28.5% | +28.5% | |
| Quarterly Net Income | $49.82M | +7.8% | +8.9% | +5.0% | +5.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $116.59M | at high | |
| 3Y | $116.59M | at high | |
| 5Y | $116.59M | at high | |
| All | $116.59M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $74.70M | N/A | +56.1% |
| 3Y | $74.70M | +56.1% | |
| 5Y | $74.70M | +56.1% | |
| All | $74.70M | +56.1% |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $116.59M | +3.4% | |
| $112.71M | +12.3% | |
| $100.39M | +34.4% | |
| $74.70M | -26.4% | |
| $101.45M | -0.4% |
| Month | Value | Change |
|---|---|---|
| $101.81M | +8.7% | |
| $93.70M | -6.5% | |
| $100.24M | +7.1% | |
| $93.57M | - |
FAQ
What is the current quarterly EBITDA of CON?
As of today, CON quarterly EBITDA is $116.59M
What is CON quarterly EBITDA most recent change?
CON quarterly EBITDA was up +3.44% on September 30, 2025
What is 1-year change in CON quarterly EBITDA?
CON quarterly EBITDA is up +14.92% year-over-year
How far is CON quarterly EBITDA from its all-time high?
CON quarterly EBITDA is currently at its all-time high
How does CON quarterly EBITDA rank versus sector peers?
CON quarterly EBITDA is higher than 89.52% of companies in Healthcare sector
When is CON next earnings release?
The next earnings release for CON is on
TTM EBITDA
$404.39M$15.14M+3.89%
Summary
- Current Value
- As of today, CON TTM EBITDA is $404.39M, up +3.89% on
- Historical Performance
- CON TTM EBITDA is up +36.18% year-over-year, and up +332.18% over the past 3 years
- All-Time High Comparison
- CON TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CON TTM EBITDA is +332.18% above its 3-year low of $93.57M reached on
- Sector Comparison
- CON TTM EBITDA is higher than 89.43% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $404.39M | +3.9% | +36.2% | +332.2% | +332.2% | |
| Annual EBITDA | $368.27M | – | +2.3% | -5.5% | -5.5% | |
| Quarterly EBITDA | $116.59M | +3.4% | +14.9% | +24.6% | +24.6% | |
| Price | $19.90 | -4.7% | +0.8% | – | – | |
| PE Ratio | 16.71 | -4.7% | +11.0% | – | – | |
| TTM Revenue | $2.09B | +4.2% | +45.6% | +357.9% | +357.9% | |
| TTM EPS | $1.19 | +2.0% | +4.1% | +225.8% | +225.8% | |
| TTM EBIT | $333.25M | +3.2% | +35.8% | +342.8% | +342.8% | |
| TTM Net Income | $159.46M | +2.6% | +7.0% | +236.2% | +236.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $404.39M | at high | |
| 3Y | $404.39M | at high | |
| 5Y | $404.39M | at high | |
| All | $404.39M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $371.66M | N/A | +8.8% |
| 3Y | $93.57M | +332.2% | |
| 5Y | $93.57M | +332.2% | |
| All | $93.57M | +332.2% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $404.39M | +3.9% | |
| $389.25M | +2.9% | |
| $378.35M | +1.8% | |
| $371.66M | +25.2% | |
| $296.96M | +51.9% |
| Month | Value | Change |
|---|---|---|
| $195.51M | +0.8% | |
| $193.94M | +0.1% | |
| $193.81M | +107.1% | |
| $93.57M | - |
FAQ
What is the current TTM EBITDA of CON?
As of today, CON TTM EBITDA is $404.39M
What is CON TTM EBITDA most recent change?
CON TTM EBITDA was up +3.89% on September 30, 2025
What is 1-year change in CON TTM EBITDA?
CON TTM EBITDA is up +36.18% year-over-year
How far is CON TTM EBITDA from its all-time high?
CON TTM EBITDA is currently at its all-time high
How does CON TTM EBITDA rank versus sector peers?
CON TTM EBITDA is higher than 89.43% of companies in Healthcare sector
When is CON next earnings release?
The next earnings release for CON is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- CON Official Website www.concentra.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2014596/000201459625000046/0002014596-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2014596/000201459625000011/0002014596-25-000011-index.htm
- CON Profile on Yahoo Finance finance.yahoo.com/quote/CON
- CON Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/con